| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |